Dr Tom Bird, Consultant Clinical Oncologist at Bristol Haematology and Oncology Center, UK, discusses how he treats people with oesophageal cancer.  This includes, locally advanced adenocarcinoma including staging, systemic and radiotherapy treatment, metastatic/recurrent adenocarcinoma (which includes an update on the treatment of gastric cancer treatment -alongside GOJ cancer -that we discussed in the prior gastric cancer podcast) including both systemic agents and palliative radiotherapy, and how treatment differs with squamous cell histology.

This podcast is an overview of the current oncology treatment of oesophageal cancer at a registrar level and is aimed at those training in oncology in the UK.

Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.

Dr Tom Bird, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with gastric cancer.  We cover scenarios including both operable gastric cancer and those with recurrent and de-novo metastatic cancer including systemic agents and palliative radiotherapy.  This podcast is an overview of the current oncology treatment of gastric cancer at registrar level and is aimed at those training in oncology in the UK.

Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.

This is the second interview with Dr Tom Strawson-Smith, Consultant Clinical Oncologist, at Bristol Haematology and Oncology Centre, UK, concluding the overview of how to manage colorectal cancer.  He discusses how he treats people who have metastatic colorectal cancer, both widely metastatic and those with oligo-metastatic disease, focusing on the use of systemic treatments.  This podcast is an overview of current oncology treatment of metastatic colorectal cancer at registrar level.

Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.

Dr Tom Strawson-Smith, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, discusses how he treats people with initial colorectal cancer.  We cover chemotherapy use in colon cancer, chemo-radiotherapy in rectal cancer including how to plan the radiotherapy, DPD deficiency and ongoing areas of research.  This podcast is an overview of the current oncology treatment of intial CRC at registrar level.

Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.

Dr Axel Walther, Consultant Medical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with recurrent ovarian cancer.  He also recaps on the use of PARP inhibitors in initial advanced ovarian cancer.  He is a great font of knowledge on ovarian cancer and the trials that underpin the treatment options, so this podcast will be a very useful overview of the UK current treatment paradigms at registrar level.

Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.

Dr Axel Walter, Consultant Medical Oncologist at Bristol Haematology and Oncology Center, kicks off the series about how to manage ovarian cancer.  He discusses in depth the staging system and how women with initial ovarian cancer should be treated, including both those with stage 1 and stage 3 disease.  This includes an explanation regarding BRCA and HRD (homologous recombination deficiency) testing and treatment with adjuvant PARP inhibitors.

Your host is Dr Alison Cameron, Bristol, UK.

Dr Charlie Comins, Consultant Clinical Oncologist at the Bristol Haematology and Oncology Centre, UK, joins us for the final podcast in the breast cancer series.  He discusses how to treat a woman with metastatic triple negative breast cancer including use of new immunotherapies, if she was diagnosed after adjuvant chemotherapy or de novo metastatic disease.

Your host is Dr Alison Cameron,Bristol, UK.

Dr Charlie Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Center, UK joins us again to discuss how to manage the care of a woman with metastatic HER2+ breast cancer, including the management of her brain metastases,  multiple lines of potential treatments and if she was diagnosed post adjuvant therapy, during adjuvant therapy or at inital diagnosis of breast cancer.

Your host is Dr Alison Cameron, Bristol, UK.

Dr Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, specialist in Breast and Lung Cancer, explains how he approaches the management of a woman with ER positive metastatic breast cancer, including how to treat bone metastases.

Your host is Dr Alison Cameron, Clinical Oncologist, Bristol, UK.  The Bristol Oncology Podcasts series is a teaching resource aimed at oncology registrars in the UK, but is applicable internationally.  For more information please go to www.ace-rt.com/learn

This interview is with Miss Michelle Mullan, Consultant Oncoplastic Breast Surgeon at Bristol who gives her perspective on the  surgical treatment of early breast cancer.  This podcast is aimed at those training in oncology.  This completes the 5 podcasts on early breast cancer, considering the treatment from an oncological view.

Your host is Dr Alison Cameron, Clinical Oncologist, Bristol, UK. This series is a teaching resource aimed oncology registrars in the UK, but is applicable internationally.  For more information please go to www.ace-rt.com/learn